TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 308 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,098,137 | -29.4% | 128,405 | -30.4% | 0.00% | 0.0% |
| Q2 2023 | $2,970,016 | +219.1% | 184,473 | +209.4% | 0.00% | – |
| Q4 2022 | $930,683 | +18.6% | 59,621 | -1.3% | 0.00% | – |
| Q3 2022 | $785,000 | -2.1% | 60,398 | +4.8% | 0.00% | – |
| Q2 2022 | $802,000 | +1.4% | 57,648 | +5.2% | 0.00% | – |
| Q1 2022 | $791,000 | +36.4% | 54,780 | +29.6% | 0.00% | – |
| Q4 2021 | $580,000 | -67.5% | 42,283 | -61.0% | 0.00% | -100.0% |
| Q3 2021 | $1,783,000 | -52.5% | 108,496 | -51.3% | 0.00% | -50.0% |
| Q2 2021 | $3,751,000 | +900.3% | 222,903 | +913.5% | 0.00% | – |
| Q1 2021 | $375,000 | -11.6% | 21,993 | -4.9% | 0.00% | – |
| Q4 2020 | $424,000 | +9.8% | 23,138 | +4.8% | 0.00% | – |
| Q3 2020 | $386,000 | +14.5% | 22,080 | +13.3% | 0.00% | – |
| Q2 2020 | $337,000 | -17.2% | 19,483 | -29.5% | 0.00% | – |
| Q1 2020 | $407,000 | -79.4% | 27,645 | -72.4% | 0.00% | -100.0% |
| Q4 2019 | $1,976,000 | +14.6% | 100,176 | +0.0% | 0.00% | 0.0% |
| Q3 2019 | $1,724,000 | +22.3% | 100,169 | +25.8% | 0.00% | 0.0% |
| Q2 2019 | $1,410,000 | -10.2% | 79,643 | +3.3% | 0.00% | 0.0% |
| Q1 2019 | $1,571,000 | – | 77,131 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 8,958,784 | $176,757,000 | 33.75% |
| Ovata Capital Management Ltd | 879,800 | $17,557,092,000 | 13.04% |
| Paulson & Co. | 13,244,711 | $261,318,000 | 5.64% |
| Glenview Capital Management | 30,582,721 | $603,397,000 | 5.28% |
| MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC | 718,028 | $14,167,000 | 4.85% |
| Velanne Asset Management Ltd | 302,694 | $5,972,000 | 3.52% |
| Blackcrane Capital, LLC | 172,708 | $3,408,000 | 2.72% |
| Melqart Asset Management (UK) Ltd | 1,557,000 | $30,720,000 | 2.57% |
| GMT CAPITAL CORP | 3,345,976 | $66,016,000 | 2.55% |
| REDWOOD CAPITAL MANAGEMENT, LLC | 827,955 | $16,336,000 | 2.24% |